Navigation Links
InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
Date:11/12/2008

Innovator of animal free and defined cell culture media components will feature its productivity maximizing products at ASCB Meeting in San Francisco Dec. 13-17, 2008.

Fort Collins, CO (PRWEB) November 12, 2008 -- InVitria InVitria announced today that it will showcase its innovative product line at the 48th Annual American Society of Cell Biology Meeting on Dec. 13-17 in San Francisco, CA. InVitria provides animal free and defined cell culture media components that are used by leading biopharmaceutical, stem cell and regenerative medicine companies around the globe.

Considered one of the largest and most diverse gatherings of the cell biology community, this year's American Society of Cell Biology (ASCB) Annual Meeting will feature over 3,500 scientific poster presentations, 350 commercial exhibits and100 learning sessions.

InVitria will showcase its product line at an exhibit booth that will provide attendees the opportunity to learn about the capabilities of InVitria's safe, reliable and productive cell culture media components. InVitria's Cellastim (recombinant albumin) and Lacromin (recombinant lactoferrin) products have shown to be powerful cell culture media enhancers.

Data from a recent study showed that Cellastim is a robust supplement for CHO media and can improve both the growth kinetics and productivity of CHO cell lines. Tests have also shown that Cellastim outperforms plasma-derived human serum albumin and can result in an average 50% increase in productivity across a variety of chemically defined cell culture media.

A global collaborative research study found that Lacromin boosts productivity in mammalian cell culture. Additionally, it was revealed that Lacromin promotes cell growth and productivity in a variety of cell lines and also improves antibody product yields in mammalian cell culture (1).

"With a primary focus of this year's ASCB Annual Meeting being the sharing of new scientific developments in the field of cell biology, we feel that attendees will be impressed at how InVitria's products benefit the cell culture industry and the work of ASCB members," said Scott Deeter, InVitria president. "We are pleased to be able to share with the cell biology community the key features of our cell culture media components, which are safety, productivity and speed to market."

About InVitria InVitria
InVitria has developed defined and animal free cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Its products include:

Cellastim Cellastim an animal free component used to enhance cell growth and productivity in cell culture media.

Lacromin Lacromin a strong growth factor for promoting cell growth and cell productivity across a variety of cell lines, including intestinal cells, hybridoma cells, osteoblast cells and HEK293 cells.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info@InVitria.com            
Phone: 1-800-916-8311

(1) Huang, N. et al. Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth. In Vitro Cellular & Developmental Biology. September 19, 2008 (E-publication Date).

###

Read the full story at http://www.prweb.com/releases/InVitria/ASCB/prweb1604992.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria to Present at WilBio's International Cell Engineering Meeting
2. SNM to showcase the latest research in molecular imaging and nuclear medicine
3. Nonin Medical, Inc. Showcases the First Pulse Oximeter Pre-Certified by the Continua Health Alliance
4. Plastic Surgery 2008 to Showcase Future of Plastic Surgery Through Groundbreaking Research
5. Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year
6. Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast
7. Emisstar Completes 2-Year Emission Control Technology Showcase
8. ACS Forum to Showcase Innovative Healthcare Model for European Union
9. Microsoft to Showcase Innovative Solutions for Health Plans at AHIP Institute 2008
10. Siemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008
11. Rite Aid Health and Beauty Expo to Showcase GNC Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: